Rallybio logo

Rallybio Share Price Today

(NASDAQ: RLYB)

Rallybio share price is $0.7 & ₹60.88 as on 6 Mar 2025, 2.30 'hrs' IST

$0.7

-0.02

(-3.28%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Rallybio share price in Dollar and Rupees. Guide to invest in Rallybio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rallybio, along with analyst recommendations, forecasts, and comprehensive financials.

Rallybio share price movements

  • Today's Low: $0.69
    Today's High: $0.73

    Day's Volatility :5.62%

  • 52 Weeks Low: $0.68
    52 Weeks High: $3.46

    52 Weeks Volatility :80.35%

Rallybio (RLYB) Returns

PeriodRallybio CorpIndex (Russel 2000)
3 Months
-32.11%
0.0%
6 Months
-35.17%
0.0%
1 Year
-61.1%
0.0%
3 Years
-92.61%
-11.6%

Rallybio (RLYB) Key Statistics

in dollars & INR

Previous Close
$0.7196
Open
$0.691
Today's High
$0.7316
Today's Low
$0.6905
Market Capitalization
$28.7M
Today's Volume
$4.2K
52 Week High
$3.46
52 Week Low
$0.68
Revenue TTM
$598.0K
EBITDA
$-66.6M
Earnings Per Share (EPS)
$-1.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-68.9%

How to invest in Rallybio Stock (RLYB) from India?

It is very easy for Indian residents to invest directly in Rallybio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rallybio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rallybio or RLYB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rallybio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rallybio shares which would translate to 1.242 fractional shares of Rallybio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rallybio, in just a few clicks!

Returns in Rallybio (RLYB) for Indian investors in Rupees

The Rallybio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rallybio investment value today

Current value as on today

₹42,801

Returns

₹57,199

(-57.2%)

Returns from Rallybio Stock

₹62,162 (-62.16%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Rallybio (RLYB)

64%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Rallybio Stock from India on INDmoney has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Rallybio

  • Viking Global Investors LP

    10.11%

  • Johnson & Johnson

    8.76%

  • 5AM Venture Management, LLC

    8.75%

  • New Leaf Venture Partners, L.L.C.

    7.96%

  • TPG GP A, LLC

    7.30%

  • Pivotal bioVenture Partners Investment Advisor LLC

    5.80%

Analyst Recommendation on Rallybio

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Rallybio(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
12
13
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Rallybio Stock (RLYB)

What analysts predicted

Upside of 1078.57%

Target:

$8.25

Current:

$0.70

Insights on Rallybio Stock (Ticker Symbol: RLYB)

  • Price Movement

    In the last 3 years, RLYB stock has moved down by -92.7%
  • RLYB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 123.5%
  • RLYB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 140.4%
  • Price to Sales

    ForRLYB every $1 of sales, investors are willing to pay $51.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Rallybio Technicals Summary

Sell

Neutral

Buy

Rallybio is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Rallybio (RLYB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rallybio Corp logo
-16.34%
-35.17%
-61.1%
-92.61%
-94.9%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rallybio Corp logo
NA
NA
NA
-1.44
-0.69
-0.39
NA
1.71
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rallybio Corp logo
Buy
$28.7M
-94.9%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Rallybio

Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that has completed Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT); and RLYB211 for the prevention of FNAIT. The company is also developing RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB331, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. It entered into a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases; and collaboration agreement with Johnson & Johnson to provide pregnant individuals therapeutic solutions at risk of fetal and neonatal alloimmune thrombocytopenia. The company was founded in 2018 and is headquartered in New Haven, Connecticut.
Organization
Rallybio
Employees
25
CEO
Dr. Stephen Uden M.B, M.D.
Industry
Miscellaneous

Management People of Rallybio

NameTitle
Dr. Martin W. MacKay Ph.D.
Co-Founder & Chairman
Dr. Stephen Uden M.B, M.D.
Co-Founder, President, CEO & Director
Mr. Jonathan I. Lieber M.B.A.
CFO & Treasurer
Dr. Steven W. Ryder F.A.C.P, M.D.
Chief Medical Officer

Important FAQs about investing in RLYB Stock from India :

What is Rallybio share price today?

Rallybio share price today stands at $0.70, Open: $0.69 ; Previous Close: $0.72 ; High: $0.73 ; Low: $0.69 ; 52 Week High: $3.46 ; 52 Week Low: $0.68.

The stock opens at $0.69, after a previous close of $0.72. The stock reached a daily high of $0.73 and a low of $0.69, with a 52-week high of $3.46 and a 52-week low of $0.68.

Can Indians buy Rallybio shares?

Yes, Indians can invest in the Rallybio (RLYB) from India.

With INDmoney, you can buy Rallybio at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rallybio at zero transaction cost.

How can I buy Rallybio shares from India?

It is very easy to buy Rallybio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rallybio (RLYB) be purchased?

Yes, you can buy fractional shares of Rallybio with INDmoney app.

What are the documents required to start investing in Rallybio stocks?

To start investing in Rallybio, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rallybio Stock (RLYB)?

Today’s highest price of Rallybio (RLYB) is $0.73.

Today’s lowest price of Rallybio (RLYB) is $0.69.

What is today's market capitalisation of Rallybio?

Today's market capitalisation of Rallybio RLYB is 28.7M

What is the 52 Week High and Low Range of Rallybio Stock (RLYB)?

  • 52 Week High

    $3.46

  • 52 Week Low

    $0.68

What are the historical returns of Rallybio (RLYB)?

  • 1 Month Returns

    -16.34%

  • 3 Months Returns

    -35.17%

  • 1 Year Returns

    -61.1%

  • 5 Years Returns

    -94.9%

Who is the Chief Executive Officer (CEO) of Rallybio ?

Dr. Stephen Uden M.B, M.D. is the current Chief Executive Officer (CEO) of Rallybio.